Sign up for the QMED & MD+DI Daily newsletter.
October 10, 2012
1 Min Read
The past week has seen a number of medical device company acquisitions, among them Boston Scientific's acquisition of Rhythmia Medical, a developer of mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter. Meanwhile, Forbes worries that the Affordable Care Act, including the medical device excise tax, will harm medical device innovation.
Study Finds Approval Time for Medical Devices Often Lags (DOTmed News)
You May Also Like
Pedersen's POV graphic featuring the headshot of MD+DI Senior Editor Amanda Pedersen and a pull quote from the latest edition of her opinion column.
BioSig's Ridiculously Sparse Layoff Announcement Reeks of CallousnessFeb 26, 2024|3 Min Read
Sourcing Electrical Components: Are We Back to Normal?Feb 26, 2024|6 Min Read
Your Smartwatch Can’t Measure Blood Glucose Levels… YetFeb 26, 2024|3 Min Read
Medtech in a Minute: Medtronic Pulls the Plug on Ventilators and MoreFeb 26, 2024|1 Min Read